Clinical Trials
40 trialsOpen-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
M.D. Anderson Cancer Center
FOLICOLOR
University Hospital, Antwerp
COLOSSUS
Cancer Trials Ireland
Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
Chinese PLA General Hospital
Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Tianjin Medical University Cancer Institute and Hospital
Assessment of the Dose Safety and Efficacy of Serine Combined With Fluorouracil Drugs
The First Affiliated Hospital of Xinxiang Medical College
Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
SUPβORT
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
Tasly Biopharmaceuticals Co., Ltd.
Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer
Shanghai East Hospital
A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer
West China Hospital
Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer
Zhejiang Cancer Hospital
Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer
Zhejiang Cancer Hospital
STREAM
National Cancer Institute, Naples
A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan.
Sun Yat-sen University
Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules
Fudan University
Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University
Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world Study
ChineseAMS
Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study
Fujian Cancer Hospital
LEAC-102 for Advanced Colorectal Cancer
Taiwan Leader Biotech Corp.
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer
Guangzhou University of Traditional Chinese Medicine
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
A-REPEAT
Hellenic Cooperative Oncology Group
Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment
PharmaMar
Second-line Surufatinib Combined With Chemotherapy in Advanced CRC
Fujian Cancer Hospital
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
Asan Medical Center
A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
DISTINCTIVE
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors
Eisai Inc.
Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer
Xiyuan Hospital of China Academy of Chinese Medical Sciences
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
University of Southern California
Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer
Taiho Pharmaceutical Co., Ltd.
OXCE
Shanghai Jiao Tong University School of Medicine
Study of Nimotuzumab to Treat Colorectal Cancer
Peking University
Efficacy Study of TKcell in Advanced Colorectal Cancer
Binex
High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study
University Hospital, Ghent